Detection of autoantibody to aldolase B in sera from patients with troglitazone-induced liver dysfunction
- 1 December 2005
- journal article
- Published by Elsevier in Toxicology
- Vol. 216 (1) , 15-23
- https://doi.org/10.1016/j.tox.2005.07.012
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 30 references indexed in Scilit:
- Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical PerspectiveChemical Research in Toxicology, 1998
- Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: Model autoantigens to study drug-induced, virus-induced, and autoimmune liver diseaseHepatology, 1997
- Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.Journal of Clinical Investigation, 1996
- Human Cytochrome P450 2E1 Is a Major Autoantigen Associated with Halothane HepatitisChemical Research in Toxicology, 1996
- How can cryptic epitopes trigger autoimmunity?The Journal of Experimental Medicine, 1995
- Mechanisms of halothane toxicity: Novel insightsPharmacology & Therapeutics, 1993
- Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72Chemical Research in Toxicology, 1993
- Immunity to Halothane Metabolite-Modified Proteins in Halothane HepatitisAnnals of the New York Academy of Sciences, 1993
- The Immunologic and Metabolic Basis of Drug HypersensitivitiesAnnual Review of Pharmacology and Toxicology, 1988
- Autoantibody to aldolase in acute and chronic hepatitisPathology, 1987